1. Corifollitropin α followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of a multicentre randomised trial
- Author
-
Konstantinos Pantos, Nikolaos P. Polyzos, Joaquin Llacer, Michel Camus, Herman Tournaye, Surgical clinical sciences, Faculty of Medicine and Pharmacy, Department of Embryology and Genetics, and Reproduction and Genetics
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Gestational sac ,poor ovarian responder ,Intracytoplasmic sperm injection ,Statistical significance ,Protocol ,medicine ,Gynecology ,Pregnancy ,In vitro fertilisation ,business.industry ,hpHMG ,corifollitropin alfa ,General Medicine ,medicine.disease ,Bologna criteria ,Exact test ,medicine.anatomical_structure ,Reproductive Medicine ,IVF ,poor ovarian responders ,Gestation ,pregnancy ,Menotropin ,business - Abstract
Background: Poor response to ovarian stimulation affects a significant proportion of infertile couples undergoing in vitro fertilisation (IVF) treatment. Recently, the European Society of Human Reproduction and Embryology developed new criteria to define poor ovarian response, the so-called Bologna criteria. Although preliminary studies in these patients demonstrated very low pregnancy rates, a recent pilot study has shown promising results in women
- Published
- 2013
- Full Text
- View/download PDF